Chemoinformaics analysis of DIHYDRO-BETA-CYCLOPYRETHROSIN
| Molecular Weight | 308.374 | nRot | 1 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 18 |
| Exact Molecular Weight | 308.162 | nRing | 3 |
| Solubility: LogS | -2.092 | nHRing | 1 |
| Solubility: LogP | 1.329 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 48.403 |
| nHD | 1 | BPOL | 29.285 |
| QED | 0.591 |
| Synth | 4.651 |
| Natural Product Likeliness | 3.48 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.006 |
| HIA | 0.311 |
| CACO-2 | -4.811 |
| MDCK | 0.000168162 |
| BBB | 0.948 |
| PPB | 0.364814 |
| VDSS | 0.834 |
| FU | 0.676147 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.081 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.499 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.11 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.117 |
| CYP3a4-sub | 0.279 |
| CL | 9.747 |
| T12 | 0.128 |
| hERG | 0.009 |
| Ames | 0.018 |
| ROA | 0.889 |
| SkinSen | 0.027 |
| Carcinogencity | 0.069 |
| EI | 0.013 |
| Respiratory | 0.711 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.855349 |